895535-15-6 Usage
Molecular weight
332.1 g/mol, which is the sum of the atomic weights of all the atoms in the molecule.
Molecular structure
The compound consists of a benzimidazole ring with a carboxylic acid group (-COOH) attached to the ring, and a 6-fluoro-4-iodo substitution pattern on the ring. The 1,1-dimethylethyl ester functional group (-OC(CH3)3) is also attached to the ring.
Physical properties
The specific physical properties of the compound are not provided in the material, but based on its molecular structure, it is likely a solid at room temperature with a high melting point.
Chemical properties
The compound has functional groups that can undergo various chemical reactions, such as ester hydrolysis, amide formation, and nucleophilic substitution.
Uses
The compound is used in organic synthesis and pharmaceutical research as a potential building block for the development of new drugs. Its specific properties and potential applications in various fields make it an important compound for further study and potential commercialization in the future.
Check Digit Verification of cas no
The CAS Registry Mumber 895535-15-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,5,5,3 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 895535-15:
(8*8)+(7*9)+(6*5)+(5*5)+(4*3)+(3*5)+(2*1)+(1*5)=216
216 % 10 = 6
So 895535-15-6 is a valid CAS Registry Number.
InChI:InChI=1S/C12H12FIN2O2/c1-12(2,3)18-11(17)16-6-15-10-8(14)4-7(13)5-9(10)16/h4-6H,1-3H3
895535-15-6Relevant articles and documents
TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
-
, (2008/06/13)
Compounds of the formula I, II or III; or pharmaceutically acceptable salts thereof, wherein m, n, q, Ar, R1, R2, R3, R4 and R5 are as defined herein. Also provided are methods for preparing, compositions comprising, and methods for using compounds of formulas I-III.
TETRALIN AND INDANE DERIVATIVES AND USES THEREOF
-
Page/Page column 112; 113, (2008/06/13)
Compounds of the formula (I), or pharmaceutically acceptable salts thereof, wherein R2 is (CR3R4)n-NR5R6 and m, p, q, Ar, R1, R3, R4, R5 and R6 are as defined in the claims, which are selective antagonists of 5-HT6 and/or 5-HT2A. Also provided are compositions comprising these compounds and their use in the preparation of medicaments for treating central nervous system disease states selected from psychoses, schizophrenia, manic depressions, neurological disorders, memory disorders, attention deficit disorder, Parkinson’s disease, amyotrophic lateral scierosis, Alzheimer’s disease, food uptake disorders and Huntington’s disease.
